GlaxoSmithKline PLC
21 January 2005
Issued - Friday 21st January 2005, London - LSE Announcement
GLAXOSMITHKLINE PLC
ANNOUNCES A CHANGE TO THE AUDIT COMMITTEE
AUDIT COMMITTEE
The Board has appointed Sir Deryck Maughan a member of the Audit Committee, with
immediate effect.
A table showing the membership of the Board and its committees with effect from
21st January 2005 is attached to this announcement.
S M Bicknell
Company Secretary
21st January 2005
BOARD AND COMMITTEE MEMBERSHIP
WITH EFFECT FROM 21ST JANUARY 2005.
Sir Christopher Gent Chairman
Sir Ian Prosser Senior Independent Non-Executive Director
Dr J-P Garnier Chief Executive Officer
Mr J D Coombe Chief Financial Officer
Dr Tachi Yamada Executive Director, Chairman, Research & Development
Mr H Lawrence Culp Independent Non-Executive Director
Sir Crispin Davis Independent Non-Executive Director
Sir Deryck Maughan Independent Non-Executive Director
Dr Ronaldo Schmitz Independent Non-Executive Director
Dr Lucy Shapiro Non-Executive Director
Sir Robert Wilson Independent Non-Executive Director
Board Committee Committee Chairman Members
Audit Dr Ronaldo Schmitz Sir Deryck Maughan
Sir Ian Prosser
Sir Robert Wilson
Remuneration Sir Robert Wilson Mr H Lawrence Culp Jnr.
Sir Crispin Davis
Nominations Sir Christopher Gent Sir Ian Prosser
Dr Ronaldo Schmitz
Corporate Responsibility Sir Christopher Gent Sir Ian Prosser
Dr Lucy Shapiro
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.